PUBLICATIONS

A New and Safe Blood Test is Transforming Prenatal Care, Doctor's Say - The Washington Post

Read A New and Safe Blood Test is Transforming Prenatal Care on Capsprenatal.com or continue to the article on www.washingtonpost.com.

Sequencing of Circulating Cell-free DNA during Pregnancy

Bianchi DW, Chiu RWK. Sequencing of Circulating Cell-free DNA during Pregnancy. The New England Journal of Medicine. 2018; 379:464-473.

https://www.nejm.org/doi/full/10.1056/NEJMra1705345

An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population

Benn P, Curnow KJ, Chapman S, Michalopoulos SN, Hornberger J, Rabinowitz M. An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population. PLoS One. 2015;10(7):e0132313.

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132313

Prenatal Screening for Fetal Aneuploidies with Cell-Free DNA in the General Pregnancy Population: A Cost-Effectiveness Analysis

Fairbrother G, Burigo J, Sharon T, Song K. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis. J Matern Fetal Neonatal Med. 2015:1-5.

http://www.tandfonline.com/doi/full/10.3109/14767058.2015.1038703

A Cost-Effectiveness Analysis of First Trimester Non- Invasive Prenatal Screening for Fetal Trisomies in the United States

Walker BS, Nelson RE, Jackson BR, Grenache DG, Ashwood ER, Schmidt RL (2015) A Cost-Effectiveness Analysis of First Trimester Non- Invasive Prenatal Screening for Fetal Trisomies in the United States. PLoS ONE 10(7): e0131402.

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0131402